Exchange Announcement • 10 Dec 2024 06:12
Exchange Announcement • 10 Dec 2024 05:45
Exchange Announcement • 07 Nov 2024 05:15
Exchange Announcement • 07 Nov 2024 05:10
Exchange Announcement • 18 Sep 2024 05:00
ENTITY
REGENXBIO Inc (RGNX US)
REGENXBIO Inc (RGNX US)
27
Analysis
Health Care • United States
REGENXBIO Inc. operates as a biotechnology company. The Company focuses on the development, commercialization, and licensing of recombinant, and adeno-associated virus gene therapy. REGENXBIO serves customers worldwide.
more
x